Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tétaud

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Immunology|December 1, 1991
Sequential shifts in the three major glycosphingolipid series are associated with B cell differentiationJ Wiels, M Mangeney, C Tétaud, et al.
Biochimica Et Biophysica Acta|January 3, 1995
Sequential changes in glycolipid expression during human B cell differentiation: enzymatic basesS Taga, C Tétaud, M Mangeney, et al.
Molecular Immunology|November 1, 1991
Analysis of phenotypic and functional changes during ganglioside-induced inhibition of human T cell proliferationC Pique, Y Mahé, C Scamps, et al.
Glycoconjugate Journal|August 1, 1996
Histo-blood group p: biosynthesis of globoseries glycolipids in EBV-transformed B cell linesJ Wiels, S Taga, C Tétaud, et al.
Leukemia|May 8, 2009
Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cellsB Renouf, E Hollville, A Pujals, et al.
Blood|February 13, 2001
Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotidesC Capoulade, L M Mir, K Carlier, et al.
Blood|November 5, 1997
Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cellsS Taga, K Carlier, Z Mishal, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Immunology|December 1, 1991
Sequential shifts in the three major glycosphingolipid series are associated with B cell differentiationJ Wiels, M Mangeney, C Tétaud, et al.
Biochimica Et Biophysica Acta|January 3, 1995
Sequential changes in glycolipid expression during human B cell differentiation: enzymatic basesS Taga, C Tétaud, M Mangeney, et al.
Molecular Immunology|November 1, 1991
Analysis of phenotypic and functional changes during ganglioside-induced inhibition of human T cell proliferationC Pique, Y Mahé, C Scamps, et al.
Glycoconjugate Journal|August 1, 1996
Histo-blood group p: biosynthesis of globoseries glycolipids in EBV-transformed B cell linesJ Wiels, S Taga, C Tétaud, et al.
Leukemia|May 8, 2009
Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cellsB Renouf, E Hollville, A Pujals, et al.
Blood|February 13, 2001
Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotidesC Capoulade, L M Mir, K Carlier, et al.
Blood|November 5, 1997
Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cellsS Taga, K Carlier, Z Mishal, et al.
Pageof 1